Nebius Group (NASDAQ:NBIS) Trading 10.9% Higher - Time to Buy?

Key Points

• Shares jumped 10.9% to about $195 after Nebius agreed to acquire Eigen AI for roughly $643 million, a move investors say should accelerate production‑AI workloads on its Token Factory platform and is supported by a large contracted backlog and recent financing to scale into 2026.
• Key risks include capEx funding and modest operating cash flow (FY25 OCF ~ $402M), which could require dilution or refinancing, and elevated valuation/high beta that would amplify downside if Nebius misses ARR/cash‑flow targets or the Eigen integration is delayed.
• Analyst and institutional interest is strong (average MarketBeat rating "Moderate Buy" with a ~$154.75 target and some firms at $150–$200), but the company recently missed EPS and revenue estimates and insiders have sold shares, making upcoming Q1 results and management commentary potential sentiment catalysts.

Shares of Nebius Group N.V. (NASDAQ:NBIS - Get Free Report) traded up 10.9% on Wednesday . The stock traded as high as $195.99 and last traded at $195.09. 19,107,328 shares changed hands during trading, an increase of 24% from the average session volume of 15,428,638 shares. The stock had previously closed at $175.92.

Key Nebius Group News

Here are the key news stories impacting Nebius Group this week:

• Positive Sentiment: Nebius agreed to acquire Eigen AI for about $643 million to add model-optimization and inference capabilities to its Token Factory platform — a deal investors see as accelerating Nebius’s ability to capture production AI workloads and improve gross margins. Read More.
• Positive Sentiment: Large contracted backlog and recent financing provide revenue visibility and capital to scale capacity into 2026 guidance; that institutional momentum helped drive the recent breakout to all‑time highs. Read More.
• Positive Sentiment: Media and analyst coverage turned bullish after the acquisition and broader AI spending themes, attracting fresh institutional demand and lifting the stock’s momentum. Read More.
• Neutral Sentiment: Insider sale: Director Elena Bunina sold 5,882 shares under a pre‑arranged Rule 10b5‑1 plan — disclosed and repetitive, so it’s more liquidity management than a clear negative signal. Read More.
• Neutral Sentiment: Near‑term catalyst: Q1 earnings (reporting in mid‑May) and management commentary on ARR, hyperscaler deployments and timing for Eigen integration could swing sentiment sharply in either direction. Read More.
• Negative Sentiment: CapEx funding and operating cash flow remain key risks — FY25 OCF was modest (~$402M, boosted by customer advances), and management’s plan implies significant incremental funding needs to hit 2026 capex guidance, which could mean dilution or refinancing risk. Read More.
• Negative Sentiment: Valuation and execution risk: the stock’s rapid run and high expectations increase downside if Nebius misses ARR/cash‑flow targets or if Eigen integration/scale‑up is delayed. High beta magnifies potential swings. Read More.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the stock. Compass Point assumed coverage on shares of Nebius Group in a research note on Wednesday, February 18th. They set a "buy" rating and a $150.00 target price for the company. Wolfe Research assumed coverage on shares of Nebius Group in a research note on Thursday, April 16th. They set a "peer perform" rating for the company. Bank of America assumed coverage on shares of Nebius Group in a research note on Tuesday, March 24th. They set a "buy" rating and a $150.00 target price for the company. Morgan Stanley assumed coverage on shares of Nebius Group in a research note on Thursday, January 15th. They set an "equal weight" rating and a $126.00 target price for the company. Finally, DA Davidson upped their price target on shares of Nebius Group from $150.00 to $200.00 and gave the stock a "buy" rating in a research report on Monday, March 16th. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, Nebius Group presently has an average rating of "Moderate Buy" and an average target price of $154.75.

Nebius Group Stock Up 10.9%

The firm's 50-day moving average price is $122.29 and its 200 day moving average price is $106.24. The firm has a market cap of $49.13 billion, a P/E ratio of -133.62 and a beta of 4.03. The company has a quick ratio of 3.08, a current ratio of 3.08 and a debt-to-equity ratio of 0.89.

Nebius Group (NASDAQ:NBIS - Get Free Report) last released its quarterly earnings results on Thursday, February 12th. The company reported ($0.69) EPS for the quarter, missing the consensus estimate of ($0.42) by ($0.27). The firm had revenue of $227.70 million for the quarter, compared to the consensus estimate of $246.05 million. Nebius Group had a negative return on equity of 11.71% and a net margin of 19.02%. As a group, research analysts expect that Nebius Group N.V. will post -2.44 earnings per share for the current year.

Insider Buying and Selling at Nebius Group

In related news, insider Andrey Korolenko sold 31,357 shares of the company's stock in a transaction dated Monday, April 6th. The shares were sold at an average price of $111.20, for a total value of $3,486,898.40. Following the completion of the sale, the insider owned 585,209 shares of the company's stock, valued at $65,075,240.80. This represents a 5.09% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CTO Danila Shtan sold 13,489 shares of the company's stock in a transaction dated Tuesday, March 31st. The stock was sold at an average price of $98.78, for a total transaction of $1,332,443.42. Following the completion of the sale, the chief technology officer directly owned 307,378 shares of the company's stock, valued at $30,362,798.84. The trade was a 4.20% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 135,622 shares of company stock valued at $15,672,341.

Institutional Investors Weigh In On Nebius Group

Several institutional investors have recently bought and sold shares of the stock. Orbis Allan Gray Ltd lifted its holdings in Nebius Group by 12.4% in the second quarter. Orbis Allan Gray Ltd now owns 17,651,930 shares of the company's stock worth $976,681,000 after purchasing an additional 1,949,708 shares during the period. Fred Alger Management LLC lifted its holdings in Nebius Group by 33.4% in the third quarter. Fred Alger Management LLC now owns 10,132,279 shares of the company's stock worth $1,137,551,000 after purchasing an additional 2,536,832 shares during the period. Jericho Capital Asset Management L.P. lifted its holdings in Nebius Group by 55.7% in the third quarter. Jericho Capital Asset Management L.P. now owns 4,607,497 shares of the company's stock worth $517,284,000 after purchasing an additional 1,648,497 shares during the period. Morgan Stanley lifted its holdings in Nebius Group by 35.2% in the fourth quarter. Morgan Stanley now owns 3,704,659 shares of the company's stock worth $310,099,000 after purchasing an additional 964,984 shares during the period. Finally, Clear Street Group Inc. lifted its holdings in Nebius Group by 95.0% in the fourth quarter. Clear Street Group Inc. now owns 3,511,656 shares of the company's stock worth $293,943,000 after purchasing an additional 1,710,924 shares during the period. Institutional investors and hedge funds own 21.90% of the company's stock.

Nebius Group Company Profile

Nebius Group N.V., a technology company, builds intelligent products and services powered by machine learning and other technologies to help consumers and businesses navigate the online and offline world. The company's services include Nebius AI, an AI-centric cloud platform that offers infrastructure and computing capability for AI deployment and machine-learning oriented solutions; and Toloka AI that offers generative AI (GenAI) solutions at every stage of the GenAI lifecycle, such as data annotation and generation, model training and fine-tuning, and quality assessment of large language model for accuracy and reliability.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.